0000899243-22-012786.txt : 20220330 0000899243-22-012786.hdr.sgml : 20220330 20220330160531 ACCESSION NUMBER: 0000899243-22-012786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giffin Brett A. CENTRAL INDEX KEY: 0001892921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 22786417 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-26 0 0001492674 T2 Biosystems, Inc. TTOO 0001892921 Giffin Brett A. 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Commercial Officer Restricted Stock Units 2022-02-26 4 A 0 500000 0.00 A Common Stock 500000 500000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024. /s/ John Sprague, Attorney-in-fact 2022-03-30